Skip to main content
Log in

High-Dose Intravenous γ-Globulins for Heparin-Induced Thrombocytopenia: A Prompt Response

  • Published:
Journal of Clinical Immunology Aims and scope Submit manuscript

Abstract

Heparin-induced thrombocytopenia (HIT) is a common drug induced autoimmune condition. The thrombocytopenia is caused in most cases by an antibody directed against the complex PF4/heparin. Recently, we have induced an experimental model of HIT by idiotypic manipulation. To confirm further the idiotypic involvement of HIT, we have treated successfully three patients with HIT with high-dose intravenous γ-globulin (IVIG). Our three patients join other two cases previously reported who were treated with IVIG and point to the efficacy of this type of therapy with minimal side effects. IVIG suppression of the anti-PF4/heparin autoantibody may support the idiotypic etiology of HIT.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

REFERENCES

  1. Chong BH: Heparin-induced thrombocytopenia. Br J Haematol 84:431–439, 1995

    Google Scholar 

  2. Warkentin TE, Levine MN, Hirsh J, Horsewood P, Roberts RS, Gent M, Kelton JG: Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. N Engl J Med 332:1330–1335

  3. Blank M, Cines DB, Arepally G, Eldor A, Afek A, Shoenfeld Y: Pathogenic effect of human anti-PF4/heparin in vivo immunization with the antibody resulted in generation of mouse anti-PF4/heparin and thrombocytopenia upon exposure to heparin. Clin Exp Immunol 108:333–339, 1997

    Google Scholar 

  4. Magnani HN: Heparin-induced thrombocytopenia (HIT): An overview of 230 patients treated with Orgaran (Org 10172). Thromb Haemost 70:554–561, 1993

    Google Scholar 

  5. Greinacher A, Michels I, Liebenhoff U, Presek P, Mueller-Eckhardt C: Heparin-associated thrombocytopenia: Immune complexes are attached to the platelet membrane by the negative charge of highly sulfated oligosaccharide. Br J Haematol 84:711–716, 1993

    Google Scholar 

  6. Amiral J, Marfaing-Koka A, Wolf M, Alessi MC, Tardy B, Boyer-Neumann C, Vissac AM, Fressinaud E, Poncz M, Meyer D: Presence of autoantibodies to interleukin-8 or neutrophil-activating peptide-2 in patients with heparin-associated thrombocytopenia. Blood 88:410–416, 1996

    Google Scholar 

  7. Greinacher A, Liebenhoff U, Kiefel V, Presek P, Mueller-Eckhardt C: Heparin-associated thrombocytopenia: The effects of various IVIG preparations on antibody mediated platelet activation—a possible new indication for high dose IVIG. Thromb Haemost 71:641–645, 1994

    Google Scholar 

  8. Dwyer JM: Immunoglobulins in autoimmunity: History and mechanisms of action. Clin Exp Rheumatol 14(Suppl 15):S3, S7, 1996

    Google Scholar 

  9. Lacroix-Desmazess, Monthon L, Spalter SH, Kaveris, Kazatchkine MD: Immunoglobulins and the regulation of autoimmunity through the immune network. Clin Exp Rheumatol 14(Suppl 15):S9–S15, 1996

    Google Scholar 

  10. Amiral J, Bridey F, Dreyfus M, Vissac AM, Fressinaud E, Wolf Mmeyer D: Platelet factor 4 complexed to heparin is the target for antibodies generated in heparin-induced thrombocytopenia. Thromb Haemost 68:95–96, 1992

    Google Scholar 

  11. Greinacher A, Pötzsch B, Amiral J, Dummel V, Eichner A, Mueller-Eckhardt C: Heparin-associated thrombocytopenia: isolation of the antibody and characterization of a multimolecular PF4-heparin complex as the major antigen. Thromb Haemost 71:247–252, 1994

    Google Scholar 

  12. Kelton JG, Sheridan D, Santos A, Smith J, Steeves K, Smith C, Brown C, Murphy WG: Heparin-induced thrombocytopenia: Laboratory studies. Blood 72:925–930, 1988

    Google Scholar 

  13. Chong BH, Fawaz I, Chesterman CN, Berndt MC: Heparin-induced thrombocytopenia: Mechanism of interaction of the heparin-dependent antibody with platelets. Br J Haematol 73:235–240, 1989

    Google Scholar 

  14. Greinacher A, Michels I, Mueller-Eckhardt C: Heparin-associated thrombocytopenia: the antibody is not heparin specific. Thromb Haemost 67:545–549, 1992

    Google Scholar 

  15. Anderson GP: Insights into heparin-induced thrombocytopenia. Br J Haematol 80:504–508, 1992

    Google Scholar 

  16. Warkentin TE, Kelton JG: Heparin-induced thrombocytopenia. Prog Hemost Thromb 10:1–34, 1991

    Google Scholar 

  17. Cines DB, Tomaski A, Tannenbaum S: Immune endothelial-cell injury in heparin-associated thrombocytopenia. N Engl J Med 316:581–589, 1987

    Google Scholar 

  18. Chong BH, Castaldi PA: Heparin-induced thrombocytopenia: Further studies of the effects of heparin-dependent antibodies on platelets. Br J Haematol 64:347–354, 1986

    Google Scholar 

  19. Adelman B, Sobel M, Fujimura Y, Ruggeri ZM, Zimmerman TS: Heparin-associated thrombocytopenia: Observation on the mechanism of platelet aggregation. J Lab Clin Med 113:204–210, 1989

    Google Scholar 

  20. Demers C, Ginsberg JS, Brill-Edwards P, Panju A, Warkentin TE, Anderson DR, Turner C, Kelton JG: Rapid anticoagulation using ancrod for heparin-induced thrombocytopenia. Blood 78:2194–2197, 1991

    Google Scholar 

  21. Warkentin TE, Hayward CP, Smith CA, Kelly PM, Kelton JG: Determinants of donor platelet variability when testing for heparin-induced thrombocytopenia. J Lab Clin Med 120:371–379, 1992

    Google Scholar 

  22. Chong BH, Pilgrim RL, Cooley MAS, Chesterman CN: Increased expression of platelet IgG Fc-receptors in immune heparin-induced thrombocytopenia. Blood 81:988–993, 1993

    Google Scholar 

  23. Chong BH, Burgess J, Ismail F: The clinical usefulness of the platelet aggregation test for the diagnosis of heparin-induced thrombocytopenia. Thromb Haemost 69:344–350, 1993

    Google Scholar 

  24. Chong BH, Castaldi PA, Berndt MC: Heparin-induced thrombocytopenia: Effects of rabbit IgG, and its Fab and Fc fragments on antibody-heparin-platelet interaction. Thromb Res 55:291–295, 1989

    Google Scholar 

  25. Nurden AT, Laroche-Traineau J, Jallu V, Broult J, Durrien C, Besse P: Heparin-induced thrombocytopenia: Observations on the nature of the antibody activities and on the use of gammaglobulin concentrates in a patient with thrombotic complications. Thromb Haemost 65:796, 1991

    Google Scholar 

  26. Frame JN, Mulvey KP, Phares JC, Anderson MJ: Correction of severe heparin-associated thrombocytopenia with intravenous immunoglobulin. Ann Intern Med 111:946–947, 1989

    Google Scholar 

  27. Grau E, Linares M, Olaso MA, Ruvira J, Sanchis J: Heparin-induced thrombocytopenia—response to intravenous immunoglobulin in vivo and in vitro. Am J Hematol 39:312–313, 1992

    Google Scholar 

  28. Vender JS, Matthew EB, Silverman IM, Konowitz H, Dau PC: Heparin-associated thrombocytopenia: alternative managements. Anesth Analg 65:520–522, 1986

    Google Scholar 

  29. Isenhart CE, Brandt JT: Platelet aggregation studies for the diagnosis of heparin induced thrombocytopenia. Am J Clin Pathol 99:324–330, 1993

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Winder, A., Shoenfeld, Y., Hochman, R. et al. High-Dose Intravenous γ-Globulins for Heparin-Induced Thrombocytopenia: A Prompt Response. J Clin Immunol 18, 330–334 (1998). https://doi.org/10.1023/A:1023238915316

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1023238915316

Navigation